The  ||| S:0 E:4 ||| DT
effect  ||| S:4 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
streptozotocin  ||| S:14 E:29 ||| NN
and  ||| S:29 E:33 ||| CC
alloxan  ||| S:33 E:41 ||| NN
on  ||| S:41 E:44 ||| IN
the  ||| S:44 E:48 ||| DT
mRNA  ||| S:48 E:53 ||| JJ
expression  ||| S:53 E:64 ||| NN
of  ||| S:64 E:67 ||| IN
rat  ||| S:67 E:71 ||| JJ
hepatic  ||| S:71 E:79 ||| JJ
transporters  ||| S:79 E:92 ||| NN
in  ||| S:92 E:95 ||| IN
vivo  ||| S:95 E:100 ||| VBG
The  ||| S:100 E:104 ||| DT
effect  ||| S:104 E:111 ||| NN
of  ||| S:111 E:114 ||| IN
streptozotocin  ||| S:114 E:129 ||| NNS
( ||| S:129 E:130 ||| -LRB-
STZ ||| S:130 E:133 ||| NNP
)  ||| S:133 E:135 ||| -RRB-
and  ||| S:135 E:139 ||| CC
alloxan  ||| S:139 E:147 ||| NNS
( ||| S:147 E:148 ||| -LRB-
ALX ||| S:148 E:151 ||| NNP
)  ||| S:151 E:153 ||| -RRB-
on  ||| S:153 E:156 ||| IN
the  ||| S:156 E:160 ||| DT
hepatic  ||| S:160 E:168 ||| JJ
messenger  ||| S:168 E:178 ||| NN
RNA  ||| S:178 E:182 ||| NNP
( ||| S:182 E:183 ||| -LRB-
mRNA ||| S:183 E:187 ||| NNP
)  ||| S:187 E:189 ||| -RRB-
expression  ||| S:189 E:200 ||| NN
of  ||| S:200 E:203 ||| IN
four  ||| S:203 E:208 ||| CD
transporters  ||| S:208 E:221 ||| NNS
( ||| S:221 E:222 ||| -LRB-
Mrp2 ||| S:222 E:226 ||| NNP
,  ||| S:226 E:228 ||| ,
Mdr1 ||| S:228 E:232 ||| NNP
,  ||| S:232 E:234 ||| ,
Oct1 ||| S:234 E:238 ||| NNP
,  ||| S:238 E:240 ||| ,
and  ||| S:240 E:244 ||| CC
Oatp1 ||| S:244 E:249 ||| CD
)  ||| S:249 E:251 ||| -RRB-
was  ||| S:251 E:255 ||| VBD
studied  ||| S:255 E:263 ||| VBN
in  ||| S:263 E:266 ||| IN
the  ||| S:266 E:270 ||| DT
present  ||| S:270 E:278 ||| JJ
work ||| S:278 E:282 ||| NN
.  ||| S:282 E:284 ||| .
After  ||| S:284 E:290 ||| IN
the  ||| S:290 E:294 ||| DT
healthy  ||| S:294 E:302 ||| JJ
male  ||| S:302 E:307 ||| JJ
Wistar  ||| S:307 E:314 ||| JJ
rats  ||| S:314 E:319 ||| NNS
were  ||| S:319 E:324 ||| VBD
individually  ||| S:324 E:337 ||| RB
treated  ||| S:337 E:345 ||| VBN
by  ||| S:345 E:348 ||| IN
a  ||| S:348 E:350 ||| DT
single  ||| S:350 E:357 ||| JJ
intraperitoneal  ||| S:357 E:373 ||| JJ
injection  ||| S:373 E:383 ||| NN
of  ||| S:383 E:386 ||| IN
ALX  ||| S:386 E:390 ||| NNP
monohydrate  ||| S:390 E:402 ||| NNS
( ||| S:402 E:403 ||| -LRB-
150 mg ||| S:403 E:409 ||| FW
/ ||| S:409 E:410 ||| FW
kg ||| S:410 E:412 ||| FW
)  ||| S:412 E:414 ||| -RRB-
or  ||| S:414 E:417 ||| CC
STZ  ||| S:417 E:421 ||| NNP
( ||| S:421 E:422 ||| -LRB-
50 mg ||| S:422 E:427 ||| FW
/ ||| S:427 E:428 ||| FW
kg ||| S:428 E:430 ||| FW
) ||| S:430 E:431 ||| -RRB-
,  ||| S:431 E:433 ||| ,
the  ||| S:433 E:437 ||| DT
hepatic  ||| S:437 E:445 ||| JJ
mRNA  ||| S:445 E:450 ||| JJ
expression  ||| S:450 E:461 ||| NN
levels  ||| S:461 E:468 ||| NNS
of  ||| S:468 E:471 ||| IN
Mrp2 ||| S:471 E:475 ||| NNP
,  ||| S:475 E:477 ||| ,
Mdr1 ||| S:477 E:481 ||| NNP
,  ||| S:481 E:483 ||| ,
Oct1 ||| S:483 E:487 ||| NNP
,  ||| S:487 E:489 ||| ,
and  ||| S:489 E:493 ||| CC
Oatp1  ||| S:493 E:499 ||| NNP
were  ||| S:499 E:504 ||| VBD
detected  ||| S:504 E:513 ||| VBN
by  ||| S:513 E:516 ||| IN
real-time  ||| S:516 E:526 ||| JJ
quantitative  ||| S:526 E:539 ||| JJ
PCR ||| S:539 E:542 ||| NNP
.  ||| S:542 E:544 ||| .
The  ||| S:544 E:548 ||| DT
results  ||| S:548 E:556 ||| NNS
indicated  ||| S:556 E:566 ||| VBD
that  ||| S:566 E:571 ||| IN
the  ||| S:571 E:575 ||| DT
mRNA  ||| S:575 E:580 ||| JJ
expression  ||| S:580 E:591 ||| NN
levels  ||| S:591 E:598 ||| NNS
of  ||| S:598 E:601 ||| IN
the  ||| S:601 E:605 ||| DT
Mrp2 ||| S:605 E:609 ||| NNP
,  ||| S:609 E:611 ||| ,
Mdr1 ||| S:611 E:615 ||| NNP
,  ||| S:615 E:617 ||| ,
Oct1 ||| S:617 E:621 ||| NNP
,  ||| S:621 E:623 ||| ,
and  ||| S:623 E:627 ||| CC
Oatp1  ||| S:627 E:633 ||| CD
in  ||| S:633 E:636 ||| IN
ALX-induced  ||| S:636 E:648 ||| JJ
diabetic  ||| S:648 E:657 ||| JJ
rats ||| S:657 E:661 ||| NNS
,  ||| S:661 E:663 ||| ,
as  ||| S:663 E:666 ||| RB
well  ||| S:666 E:671 ||| RB
as  ||| S:671 E:674 ||| IN
the  ||| S:674 E:678 ||| DT
hepatic  ||| S:678 E:686 ||| JJ
mRNA  ||| S:686 E:691 ||| JJ
expression  ||| S:691 E:702 ||| NN
of  ||| S:702 E:705 ||| IN
Mdr1  ||| S:705 E:710 ||| NNP
and  ||| S:710 E:714 ||| CC
Oatp1  ||| S:714 E:720 ||| CD
in  ||| S:720 E:723 ||| IN
STZ-induced  ||| S:723 E:735 ||| JJ
diabetic  ||| S:735 E:744 ||| JJ
rats ||| S:744 E:748 ||| NNS
,  ||| S:748 E:750 ||| ,
were  ||| S:750 E:755 ||| VBD
significantly  ||| S:755 E:769 ||| RB
decreased  ||| S:769 E:779 ||| VBD
as  ||| S:779 E:782 ||| RB
compared  ||| S:782 E:791 ||| VBN
with  ||| S:791 E:796 ||| IN
the  ||| S:796 E:800 ||| DT
control ||| S:800 E:807 ||| NN
.  ||| S:807 E:809 ||| .
The  ||| S:809 E:813 ||| DT
inhibition  ||| S:813 E:824 ||| NN
of  ||| S:824 E:827 ||| IN
ALX  ||| S:827 E:831 ||| NNP
and  ||| S:831 E:835 ||| CC
STZ  ||| S:835 E:839 ||| NNP
on  ||| S:839 E:842 ||| IN
hepatic  ||| S:842 E:850 ||| JJ
transporter  ||| S:850 E:862 ||| NN
expression  ||| S:862 E:873 ||| NN
suggested  ||| S:873 E:883 ||| VBD
that  ||| S:883 E:888 ||| DT
alterations  ||| S:888 E:900 ||| NN
of  ||| S:900 E:903 ||| IN
drug  ||| S:903 E:908 ||| NN
transporters  ||| S:908 E:921 ||| NN
under  ||| S:921 E:927 ||| IN
diabetic  ||| S:927 E:936 ||| JJ
condition  ||| S:936 E:946 ||| NN
can  ||| S:946 E:950 ||| MD
be  ||| S:950 E:953 ||| VB
responsible  ||| S:953 E:965 ||| JJ
for  ||| S:965 E:969 ||| IN
reduced  ||| S:969 E:977 ||| JJ
drug  ||| S:977 E:982 ||| NN
clearance ||| S:982 E:991 ||| NN
.  ||| S:991 E:993 ||| .
